VIDAvision

by VIDA Diagnostics  · Based in United States → — Clinical Imaging Intelligence
Cardiothoracic Surgery Pulmonology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

VIDAvision, also referred to as VIDA|vision, is an FDA-cleared imaging software developed by VIDA Diagnostics. It utilizes AI-powered deep learning algorithms to analyze chest CT scans, providing comprehensive quantitative analysis for diagnosing and monitoring various lung diseases. The software reconstructs 2D CT images into detailed 3D views and generates comprehensive reports, streamlining clinical workflows and reducing manual effort. VIDAvision supports physicians in the diagnosis, treatment planning, and documentation of chest diseases, including lung cancer, COPD, interstitial lung disease, emphysema, and asthma. Key applications include Lung Bronchoscopy Planning and Lung Volume Reduction, offering insights to optimize care decisions and improve patient outcomes.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered digital biomarkers
  • Automated deep learning-based lung and lobe segmentation
  • Quantitative CT (QCT) analysis
  • 3D reconstruction of CT images
  • Detailed quantitative analyses and reports
  • Lung Bronchoscopy Planning application
  • Lung Volume Reduction application
  • Airway analysis
  • Parenchymal density analysis
  • Streamlined imaging workflow

Use Cases

  • Diagnosis of chronic and complex lung diseases (e.g., COPD, ILD, asthma, lung cancer)
  • Monitoring progression of lung diseases
  • Personalized treatment planning for respiratory conditions
  • Procedural planning for bronchoscopy and lung volume reduction
  • Supporting clinical trials and therapeutic research
  • Documentation of chest diseases

What Physicians Need to Know

Evidence Base
VIDAvision utilizes deep learning algorithms and evidence-based quantitative CT (QCT) biomarkers for the detailed analysis of lung regions in CT images, aiming to transform pulmonology into an evidence-based practice.
Clinical Validation Studies
The software is FDA-cleared and CE/MDR certified, indicating it has met regulatory standards for clinical use. It is designed to optimize care decisions, improve patient outcomes, and reduce healthcare costs.
Alert Fatigue Management
No specific information regarding alert fatigue management features for VIDAvision was found in the provided search results. This type of feature is less common for an imaging analysis tool.
Override Rate Data
No specific information regarding override rate data for VIDAvision was found in the provided search results.
Differential Diagnosis Support
The tool aids in diagnosing and monitoring lung diseases by providing detailed quantitative analyses and 3D reconstructions of CT images. It supports interventional pulmonologists in planning diagnostic biopsy procedures for peripheral nodules through automated path planning and virtual bronchoscopy features.
Clinical Workflow Integration
VIDAvision is designed to streamline clinical workflow and reduce manual effort. It offers extensive integration with major EHR systems (e.g., Epic, Cerner/Oracle Health, Allscripts, AthenaHealth) and PACS systems (e.g., GE Healthcare PACS, Philips IntelliSpace, McKesson PACS). EHR embedding integration is available as an optional module.
Decision Audit Trail
The system includes 'audit logs' as a privacy feature, indicating a mechanism for tracking system usage and potentially decisions made within the software.
Physician Tip

Leverage VIDAvision's quantitative CT analysis and 3D reconstructions for enhanced precision in diagnosing and monitoring lung diseases. Utilize the automated path planning and virtual bronchoscopy features to improve confidence and efficiency when planning diagnostic biopsy procedures for peripheral nodules. The detailed reports can aid in optimizing care decisions and patient outcomes.

VIDAvision offers broad integration capabilities with leading EHR and PACS systems, including Epic, Cerner/Oracle Health, Allscripts, AthenaHealth, GE Healthcare PACS, and Philips IntelliSpace. This extensive compatibility facilitates seamless incorporation into existing clinical workflows, enhancing data flow and reducing manual effort. Optional EHR embedding integration further streamlines access at the point of care.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-based (VIDA Intelligence Platform)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

VIDAvision (K200990) received 510(k) clearance from the FDA on August 7, 2020. This clearance, including enhancements to its LungPrint solution, incorporates automated deep learning-based lung and lobe segmentation algorithms for improved lung imaging analysis and comprehensive assessment of disease probability and progression.
Integrations
EHR Not specified
Specialties Cardiothoracic Surgery, Pulmonology, Radiology

What the Web Says

VIDAvision, developed by VIDA Lung, is an AI-powered platform designed to assist in the early detection and management of lung diseases. It leverages advanced imaging analysis to provide quantitative insights into lung health, aiming to improve diagnostic accuracy and personalize treatment plans. Reviews highlight its potential to streamline workflows and offer a more objective assessment of lung conditions.

Overall: Positive

Strengths

  • AI-powered quantitative analysis of lung imaging
  • Aids in early detection and management of lung diseases
  • Potential for improved diagnostic accuracy
  • Supports personalized treatment planning
  • Streamlines workflow for healthcare professionals
  • Objective assessment of lung conditions

Limitations

  • Relatively new technology, long-term impact still being evaluated
  • Integration challenges with existing healthcare IT systems
  • Cost of implementation and ongoing subscriptions
  • Reliance on high-quality imaging data for accurate results
  • Potential for over-reliance on AI, overlooking clinical judgment
  • Limited independent reviews from a wide range of physicians currently available

Based on reviews from: VIDA Lung Official Website, Healthcare IT News, Radiology Today, Medical Device Network, LinkedIn (professional discussions), Company press releases

Last updated: 2026-07-20

Ratings & Reviews

Rate VIDAvision

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
VIDA Brings Power of Precision Imaging Directly to Pulmonologists with Release of VIDA|visionu2122 Clinical Software
VIDA Diagnostics, Inc. announced the release of VIDA|visionu2122, a suite of clinical software applications designed to empower pulmonary clinicians with precision informatics for optimizing care decisions, improving patient outcomes, and reducing healthcare costs. The software is cleared for clinical use in the United States, Canada, European Union, and Australia.
2016-05
HealthAidb
VIDAvision - HealthAidb
VIDAvision is an FDA-cleared imaging software by VIDA Diagnostics that uses deep learning to segment lung regions in CT images, providing quantitative analyses for diagnosing and monitoring lung diseases like cancer, COPD, and asthma. It reconstructs 2D CT images into 3D views and generates detailed reports, aiming to streamline workflow and reduce manual effort for clinicians.
2025-10
Imaging Technology News
VIDA|vision - Imaging Technology News
This page aggregates various news items related to imaging technology, with some mentions of VIDA|vision in the context of broader advancements in medical imaging and AI-powered solutions. While not a direct article about VIDA|vision, it indicates its presence within the medical imaging news landscape.
2026-06
VIDA Lung
Press Releases Archives - Clinical Imaging Intelligence - VIDA Lung
This archive contains press releases from VIDA Diagnostics, Inc., including announcements about board appointments and partnerships aimed at delivering lung analytics solutions to radiologists and care teams.
2020-08
Business Wire
Jenne, Inc. Selects Vida to Bring AI Agent Technology to its Reseller Network
Jenne, Inc. announced a partnership with Vida Global Inc., an AI agent operating system, to provide Jenne's reseller network with access to the Vida platform for delivering branded AI agent solutions to their customers.
2026-06
VIDA Private Wealth LLC
VIDA Vision Fund
The VIDA Vision Fund invests in companies shaping the future of technology and industry, focusing on artificial intelligence, robotics, and other transformative forces. This fund is distinct from VIDA Diagnostics' medical imaging software.
unknown

Videos

Product demos, reviews, and walkthroughs for VIDAvision.

Loading videos...

View all on YouTube

Frequently Asked Questions

VIDAvision is an FDA-cleared imaging software that utilizes deep learning algorithms to analyze chest CT scans. It automatically segments lung regions, reconstructs 2D CT images into 3D views, and generates detailed reports to assist clinicians in diagnosing and monitoring lung conditions such as lung cancer, COPD, and asthma. This streamlines the workflow and reduces manual effort for physicians by providing quantitative analyses and advanced visualizations.
VIDAvision provides insights designed to optimize care decisions, improve patient outcomes, and reduce healthcare costs, particularly for pulmonary clinicians. It includes applications like Lung Bronchoscopy Planning, which aids interventional pulmonologists in planning diagnostic biopsy procedures for peripheral nodules, and Lung Volume Reduction, which helps physicians select appropriate therapies for severe emphysema patients using quantitative CT biomarkers.
VIDAvision is an FDA-cleared medical device and is cleared for clinical use in the United States, Canada, the European Union, and Australia. It adheres to key compliance standards including HIPAA, SOC 2, HITRUST R2, ISO 13485:2016, and FDA Part 11, ensuring data security and regulatory adherence.
While VIDAvision offers advanced analytical capabilities, potential limitations could include the need for high-quality CT scan inputs for optimal performance of its deep learning algorithms. As with any clinical decision support tool, physician interpretation and clinical judgment remain crucial, and the software serves as an aid rather than a replacement for expert medical opinion.
While the search results provided general clinical decision support systems like UpToDate, AMBOSS, and Glass Health, which offer broad diagnostic and treatment guidance, direct named alternatives specifically for advanced AI-powered quantitative CT lung analysis like VIDAvision were not explicitly detailed. Physicians would typically look for other specialized imaging software platforms that offer similar deep learning segmentation, 3D reconstruction, and quantitative analysis for lung diseases.
VIDAvision is offered under a subscription-based pricing model. For specific pricing details and acquisition options, interested parties, whether individual practices or larger healthcare systems, are advised to contact VIDA Diagnostics directly.
VIDAvision is designed for integration with various prominent EHR systems, including Epic, Cerner/Oracle Health, Allscripts, and AthenaHealth. It also supports integration with other healthcare IT infrastructure components such as GE Healthcare PACS, Philips IntelliSpace, and DICOM Web Services, facilitating a seamless flow of imaging data and reports within the clinical environment.

Compare VIDAvision

VS
VIDAvision vs HealthPNX
Clinical Decision Support & Reference Adjacent · 60/100
These tools are adjacent in the healthcare AI landscape, both offering FDA-cleared clinical decision support for lung imaging. However, VIDAvision focuses on comprehensive quantitative analysis of CT scans…
VS
VIDAvision vs ContaCT
Clinical Decision Support & Reference Adjacent · 65/100
VIDAvision is a specialized AI-powered imaging software focused on comprehensive quantitative analysis of chest CT scans for lung diseases, providing detailed diagnostic and planning data. ContaCT by Viz.ai…
VS
VIDAvision vs Viz CTP
Clinical Decision Support & Reference Adjacent · 65/100
VIDAvision is specifically designed for comprehensive quantitative analysis of chest CT scans to aid in the diagnosis and management of various lung diseases. In contrast, Viz CTP offers…
VS
QuantX vs VIDAvision
Clinical Decision Support & Reference Adjacent · 70/100
QuantX is an FDA-cleared AI platform for computer-aided diagnosis of breast abnormalities using MRI, aimed at enhancing diagnostic accuracy for radiologists. In contrast, VIDAvision is an FDA-cleared, AI-powered…

Related Tools

Visiopharm AI-driven Precision Pathology
Visiopharm
Oncology AI
Visiopharm provides AI-driven precision pathology software for research and diagnostics, offering image analysis applications for metastasis detection and biomarker evaluation.
DeepHeme
Memorial Sloan Kettering Cancer Center (developed in collaboration with UCSF and UC Berkeley)
Lab & Diagnostics
DeepHeme is an AI tool developed by Memorial Sloan Kettering Cancer Center, UCSF, and UC Berkeley that automates the counting and classification of blood and bone marrow cells to assist in the diagnosis of blood cancers, reducing manual review time and achieving expert-level accuracy.
ScreenPoint Medical
ScreenPoint Medical
Clinical Decision Support & Reference
ScreenPoint Medical offers Transpara, an AI-powered solution for breast cancer detection and diagnosis in mammography and digital breast tomosynthesis, designed to assist radiologists.
INIFY Prostate
ContextVision
Clinical Decision Support & Reference
INIFY Prostate is an AI-based decision support tool that accurately outlines suspicious prostate cancer areas in digitalized prostate biopsy samples.
Cartesion Prime (PCD-1000A/3) V10.21
Canon Medical Systems USA, Inc.
Clinical Decision Support & Reference
The Cartesion Prime (PCD-1000A/3) V10.21 is a premium, air-cooled digital PET/CT scanner from Canon Medical Systems, featuring AI-assisted deep learning reconstruction (AiCE) for superior image quality, faster scans, and reduced dose.
DERM (by Skin Analytics)
Skin Analytics
Clinical Decision Support & Reference
DERM is an AI as a Medical Device (AIaMD) with Class III CE mark that assesses dermoscopic images of skin lesions to provide a suspected diagnosis and referral recommendation, aiming to triage patients and reduce waiting times for skin cancer assessment.

See all Oncology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.